CBondlogo-Red.png
C-Bond Systems Enters into $1 Million Exclusive Distribution Agreement for its MB-10 and FN Nano Products with Prominent Distributor in India
August 31, 2020 08:45 ET | C-Bond Systems
HOUSTON, Aug. 31, 2020 (GLOBE NEWSWIRE) -- C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, announced today that it has entered into a $1 million exclusive...
Arca Biopharma Announces Second Quarter 2020 Financial Results and Provides Corporate Update
August 05, 2020 16:15 ET | ARCA biopharma, Inc.
AB201 being developed as a potential treatment for COVID-19 and other RNA virus associated diseasesARCA anticipates filing an IND for AB201 in Q3 2020 and initiating Phase 2 clinical testing in Q4...
CBondlogo-Red.png
C-Bond Systems Reports Record Monthly Revenue of $128,000 in July
August 03, 2020 08:31 ET | C-Bond Systems
HOUSTON, Aug. 03, 2020 (GLOBE NEWSWIRE) -- C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, announced today that it has reported record monthly revenue of...
Avid Bioservices logo_no tag_RGB.jpg
Avid Bioservices and Argonaut Manufacturing Services Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Process Development, Drug Substance Manufacturing and Drug Product Parenteral Manufacturing TUSTIN, Calif. and CARLSBAD, Calif., July 28, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing...
Bio-Sig-Logo-horiz.jpg
Phase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2 Coronavirus Underway at 4 Key Trial Sites
July 13, 2020 13:42 ET | BioSig Technologies, Inc.
Westport, CT, July 13, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company") and its subsidiary, ViralClear Pharmaceuticals, Inc., today announced the...
Cambridge Security Seals Launches A-MVB™ Line of Tamper-Evident Seals Equipped to Combat the Spread of Viruses and Diseases
July 08, 2020 09:20 ET | Cambridge Security Seals
Pomona, New York, July 08, 2020 (GLOBE NEWSWIRE) -- Cambridge Security Seals (CSS), a global leader in tamper-evident seals and security solutions, today unveiled its A-MVB™ line of antimicrobial,...
CBondlogo-Red.png
C-Bond Systems Announces Exclusive Nationwide Distribution Agreement for EPA Registered Disinfectant MB-10 Tablets Approved for Use Against Human Coronavirus SARS-CoV-2
June 01, 2020 08:31 ET | C-Bond Systems
HOUSTON, June 01, 2020 (GLOBE NEWSWIRE) -- C-Bond Systems, Inc. (“C-Bond”) (OTC: CBNT), a nanotechnology solutions company, announced today that it has entered into an exclusive, nationwide...
ARCA biopharma Announces AB201 Development Program for Treatment of COVID-19 Associated Coagulopathy
May 28, 2020 08:00 ET | ARCA biopharma, Inc.
AB201 (rNAPc2) is being developed as a potential treatment for COVID Associated Coagulopathy, a condition characterized by abnormal blood clotting in patients with COVID-19Previous safety data in more...
AtrivaTherapeutics_LOGO.jpg
Atriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase II Study
May 28, 2020 03:00 ET | Atriva Therapeutics GmbH
ATR-002 mode of action inhibits SARS-CoV-2 viral propagation and prevents the cytokine storm as demonstrated in preclinical studiesAtriva’s lead product candidate is the only host-targeted antiviral...
CBondlogo-Red.png
C-Bond Systems’ Manufacturing Facility Receives EPA Registration
April 30, 2020 08:31 ET | C-Bond Systems
HOUSTON, April 30, 2020 (GLOBE NEWSWIRE) -- C-Bond Systems, Inc. (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, today announced its manufacturing facility has received...